Drugs FDA-approved for hematology / oncology in 2020: ‘Game-changing’ and ‘niche’ indications
The Food and Drug Administration has approved dozens of drugs for new hematology/oncology indications this year. Host David Henry, MD, was joined by David Mintzer, MD, and other colleagues at Penn Medicine in Philadelphia – Justine Cohen, DO, and Ingrid Kohut, DO – to discuss some of these approvals.
Dr. Mintzer reviewed:
Details on all approvals are available on the FDA website.
* * *
Disclosures:
Dr. Henry and all guests reported having no relevant disclosures.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgehemonc
David Henry on Twitter: @davidhenrymd
Create your
podcast in
minutes
It is Free